1990
DOI: 10.1210/endo-126-6-2876
|View full text |Cite
|
Sign up to set email alerts
|

Interactions between Tumor Necrosis Factor-α, Hypothalamic Corticotropin-Releasing Hormone, and Adrenocorticotropin Secretion in the Rat*

Abstract: We studied the effects of tumor necrosis factor-alpha (TNF alpha), a macrophage-derived pleiotropic cytokine produced during the inflammatory/immune response, on the function of the hypothalamic-pituitary-adrenal (HPA) axis of the rat. Intravenous injections of TNF alpha stimulated plasma ACTH and corticosterone secretion in a dose-dependent fashion. This effect was inhibited by a rat CRH antiserum that was administered to the rats 1 h before the TNF alpha injections. This suggested that CRH is a major mediato… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

6
93
0
2

Year Published

1992
1992
2007
2007

Publication Types

Select...
9

Relationship

1
8

Authors

Journals

citations
Cited by 222 publications
(101 citation statements)
references
References 0 publications
6
93
0
2
Order By: Relevance
“…Sharp et al (1989) and van der Meer et al (1996) reported that human TNF-␣ administered either into the lateral cerebroventricle or directly into the median eminence has no effect on plasma ACTH levels. Conversely, these authors (Sharp et al, 1989;van de Meer et al, 1996), as well as others (Bernardini et al, 1990;Besedovsky et al, 1991;Watanobe and Takebe, 1992;Sharp and Matta, 1993), have reported marked ACTH secretagogue activity of human TNF-␣ when administered intravenously. The apparent difference between the effects of intracerebral mouse and human TNF-␣ on plasma ACTH concentration may reflect the differing pharmacological profiles of the two identified TNF receptors, TNF-R1 and TNF-R2.…”
Section: Discussionmentioning
confidence: 90%
See 1 more Smart Citation
“…Sharp et al (1989) and van der Meer et al (1996) reported that human TNF-␣ administered either into the lateral cerebroventricle or directly into the median eminence has no effect on plasma ACTH levels. Conversely, these authors (Sharp et al, 1989;van de Meer et al, 1996), as well as others (Bernardini et al, 1990;Besedovsky et al, 1991;Watanobe and Takebe, 1992;Sharp and Matta, 1993), have reported marked ACTH secretagogue activity of human TNF-␣ when administered intravenously. The apparent difference between the effects of intracerebral mouse and human TNF-␣ on plasma ACTH concentration may reflect the differing pharmacological profiles of the two identified TNF receptors, TNF-R1 and TNF-R2.…”
Section: Discussionmentioning
confidence: 90%
“…increases hypothalamic secretion of CRF in vitro and in vivo, and passive immunoneutralization of CRF inhibits the elevation in plasma ACTH concentrations produced by each of these three cytokines Sapolsky et al, 1987;Uehara et al, 1987;Naitoh et al, 1988;Tsagarakis et al, 1989;Bernardini et al, 1990;Navarra et al, 1991;Watanobe et al, 1991;Watanobe and Takebe, 1992). In contrast, the participation of endogenous cytokines in inflammation-induced activation of the HPA axis has been less well studied and largely restricted to the study of ACTH responses to systemic administration of the bacterial cell wall product endotoxin [or lipopolysaccharide (LPS)] (Tilders et al, 1994).…”
mentioning
confidence: 99%
“…57,58 In addition, as noted above, TNFalpha effects may be mediated by induction of downstream cytokines such as IL-1, which has been shown to have a behavioral profile similar to TNFalpha in open-field testing. [40][41][42] Finally, consideration should be given to the possibility that reduced host responses to viral infection in TNF-R1-KO mice may be responsible (in relatively non-specific fashion) for the reversal of anxiety-like behaviors in glucocorticoid-deficient, MCMV-infected animals.…”
Section: Discussionmentioning
confidence: 93%
“…In addition, all three cytokines directly stimulate hypothalamic CRH secretion in vitro, an action that is also suppressed by glucocorticoids and prostanoid synthesis inhibitors. [107][108][109] There is evidence to suggest that IL-6, the main endocrine cytokine, plays the primary role in the immune stimulation of the human HPA axis. Thus, in humans, IL-6 is an extremely potent activator of the axis and lacks the vascular leak-promoting and hypotensive side effects of the other two inflammatory cytokines.…”
Section: Stress System: Immune System Interactions Effects Of the Immmentioning
confidence: 99%